I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Optimizing treatment selection and sequencing decisions for..:
Jeffrey C.H. Goh
;
Charlie Gourley
;
David S P Tan
...
http://www.sciencedirect.com/science/article/pii/S2352578922001084. , 2022
Link:
https://doi.org/10.1016/j.gore.2022.101028
RT Journal T1
Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer – International considerations amongst upper middle- and high-income countries (UMIC and HIC)
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:d8b61cfeb7db4d489058ed2b8eecf815&Exemplar=1&LAN=DE A1 Jeffrey C.H. Goh A1 Charlie Gourley A1 David S P Tan A1 Angélica Nogueira-Rodrigues A1 Hesham Elghazaly A1 Marc Edy Pierre A1 Gonzalo Giornelli A1 Byoung-Gie Kim A1 Flavia Morales–Vasquez A1 Alexandra Tyulyandina PB Elsevier YR 2022 K1 Ovarian cáncer K1 PARP inhibitors K1 Genetic testing K1 BRCA mutations K1 Olaparib K1 Gynecology and obstetrics K1 RG1-991 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://www.sciencedirect.com/science/article/pii/S2352578922001084 LK http://dx.doi.org/https://doi.org/10.1016/j.gore.2022.101028 DO https://doi.org/10.1016/j.gore.2022.101028 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)